1. M19 Differences in patient and physician viewpoints of the management of idiopathic pulmonary fibrosis (ipf). (15th November 2017) Authors: Maher, TM; Swigris, JJ; Kreuter, M; Wijsenbeek, M; Axmann, J; Ireland, L; Nathan, SD Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P161 Unmet needs in the treatment of idiopathic pulmonary fibrosis (IPF) – insights from patient chart review in five european countries. (15th November 2016) Authors: Maher, TM; Molina-Molina, M; Russell, A-M; Bonella, F; Jouneau, S; Ripamonti, E; Axmann, J; Vancheri, C Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. M28 Deferring treatment with pirfenidone results in loss of lung function that is not recovered by later treatment initiation. (15th November 2017) Authors: Maher, T; Jouneau, S; Morrison, L; Lederer, D; Molina-Molina, M; Kirchgaessler, K-U; Gilberg, F; Axmann, J; Petzinger, U; Bendstrup, E Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗